A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy
PHASE1
To assess the efficacy and safety of TQB2450 in combination with anlotinib ...
Status
Unknown
Location
Cancer Hospital Affiliated to Shandong First Medical University
Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer
PHASE2
Objective to compare the efficacy and safety of TQB2450 injection combined ...
A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).
PHASE3
This is Phase 3, randomized, open-label, parallel controlled study designed...
Status
Unknown
Location
Chinese Academy of Medical Sciences Cancer Hospital
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
PHASE2
This clinical study plans to enroll 69 endometrial cancer patients and 5-10...
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
PHASE1
Abstract Study title: Single-center, Multi-cohort Exploratory Phase Ib/II C...